Phospholipase A2 (PLA2) is a key enzyme in the formation of arachidonic acid metabolites, platelet activating factor, and lysophosphatidylcholine, all of which have been implicated in inflammatory reactions in the gastrointestinal tract. ' For example, increased values of arachidonic acid metabolites23 and platelet activating factor4 have been shown in the intestinal mucosa of patients with Crohn's disease, suggesting that intestinal PLA2 activation may play a part in the pathogenesis of this disorder. Moreover, in Crohn's disease, increase in mucosal PLA2 activity seems to precede the intestinal inflammation. 56 Detailed characterisation of the intestinal PLA2 activity, however, is as yet lacking and the precise mechanisms responsible for the increased intestinal PLA2 activity in Crohn's disease remain to be identified.
The phospholipases A2 of the gastrointestinal tract7" include both high molecular weight'0 2 and low molecular weight7 isoforms, the low molecular phospholipases A2 being divided into group I and group II types.'3 Phospholipases A2 from group I are found in large amounts in the pancreas7 and are thus thought to serve mainly as digestive enzymes." The presence of group I PLA2, however, in organs other than the pancreas, such as the lung7 and spleen,'4 suggests that group I phospholipases A2 have additional, yet unidentified, physiological functions. The rat glandular stomach contains high concentrations of messenger ribonucleic acid (mRNA) for group I PLA2,7" whereas other parts of the rat gastrointestinal tract seem to lack group I PLA2.8 Group II PLA2 mRNA, on the other hand, is more widely distributed in the rat gastrointestinal tract,9 with particularly large amounts found in the ileum.9 As group II phospholipases A2 are thought to be important in inflammatory reactions'5"17 and as the ileum is the predilection site ofCrohn's disease,'8 the question arises as to how the small intestinal group II PLA2 activity is regulated, and how it may be affected by inflammatory promoting agents.
It has previously been shown that endotoxin and dexamethasone may affect the mRNA expression of group II PLA2 in the lung and spleen of endotoxin shock rats. ' In the first experiment nine rats were injected intravenously with endotoxin (5 mg/kg body weight, dissolved in saline), and nine rats were injected with an equal volume of saline. At different time points after injection (6, 12, and 24 hours later), three rats from each group were killed. The glandular stomach and 10 cm of the distal ileum were immediately taken out and washed in ice cold saline before being freezed in liquid nitrogen and kept at -700C until analysed.
In a second experiment, 32 rats were divided into four groups with eight rats in each. One group was injected intravenously with endotoxin (5 mg/kg body weight, dissolved in saline), and one group received an intraperitoneal injection of dexamethasone (10 mg/kg body weight, dissolved in saline) 30 Group II PLA2 mRNA was detected in all tissues examined -that is, the forestomach, glandular stomach, duodenum, ileum, caecum, and colon. About the same amounts were found in the stomach, duodenum, and colon. The largest amounts were found in the distal part of ileum (Fig 1) .
EFFECT OF ENDOTOXIN ON THE PLA2 mRNA EXPRESSION
In both the glandular stomach and the distal part of ileum, the type II PLA2 mRNA expression was increased six hours after endotoxin injection, and did not seem to decline during the next 18 hours (Table) . In contrast, the glandular stomach PLA2 type I mRNA expression was not increased after endotoxin treatment (Table) . Type I PLA2 mRNA was not detected in the ileum, either before or after endotoxin treatment (data not shown).
EFFECT OF DEXAMETHASONE ON THE PLA2 mRNA EXPRESSION Twelve hours after the intravenous injection of endotoxin, the expression of PLA2 type II mRNA was significantly increased in the glandular stomach and the distal ileum (Figs 2 and 3 ), confirming the above results (Table) . When dexamethasone was given intraperitoneally 30 minutes before the endotoxin challenge, however, the increase in PLA2 type II mRNA expression after 12 hours was reduced both in the glandular stomach (Fig 2) 
t=(n=2). t=not detected (ND).
Effects ofendotoxin and dexamethasone on group I and IIphospholipase A2 in rat ileum and stomach . Dexamethasone did not significantly reduce the basal value of PLA2 type II mRNA in the stomach (Fig 2) or ileum (Fig 3) . Endotoxin did not affect the glandular stomach type I phospholipase A2 mRNA expression, and dexamethasone was without effect (Fig 4) . good correlation in ileal PLA2 enzyme activity v group II PLA2 mRNA expression (coefficient, r=0-73; p<00001) (Fig 7) .
Discussion
We have previously found that an increase in mucosal PLA2 activity precedes the recurrence of intestinal inflammation in Crohn's disease. 5 6 This finding suggests the possibility that a group II PLA2 might play a part in Crohn's disease, because group II phospholipases A2 seem to participate in other inflammatory conditions23 given saline alone (Saline) and dexamethasone alone (Dex), Group i1 phosph( 15 25 37 41 In summary, we have shown that the distal ileum is the part of the gastrointestinal tract with the most group II PLA2 mRNA, and that the expression of this mRNA, and the corresponding enzyme activity, may be affected by endotoxin and dexamethasone. We have also shown that the group II PLA2 activity and the group I PLA2 activity are regulated differently in the glandular stomach. As far as we know, this is the first study in which the regulation of group I and group II PLA2 mRNA expression has been investigated in the same organ within the same study. This study does not make clear, however, which particular cell type(s) is responsible for the stomach and ileal PLA2 activity and PLA2 mRNA expression. This problem could be considered by studying the gastrointestinal PLA2 mRNA expression after cell fractionation to yield homogenous cell populations or by in situ hybridisation. Moreover, to clarify the role of phospholipase A2 in Crohn's disease, further studies are needed to elucidate the distribution and role ofgroup I 
